{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:48:12Z","timestamp":1792082892051,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005220","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000}}],"reference-count":80,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005220.pub2","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T04:29:27Z","timestamp":1461040167000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Drugs for the acute treatment of migraine in children and adolescents"],"prefix":"10.1002","volume":"2020","author":[{"given":"Lawrence","family":"Richer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Neurology; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Billinghurst","sequence":"additional","affiliation":[{"name":"Division of Neurology; The Children's Hospital of Philadelphia; Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan A","family":"Linsdell","sequence":"additional","affiliation":[{"name":"Women and Children\u2019s Health Research Institute; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health; University of Manitoba; Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and the Alberta Research Centre for Health Evidence; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T","family":"Crumley","sequence":"additional","affiliation":[{"name":"Health Info and Searching Practice Inc; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Durec","sequence":"additional","affiliation":[{"name":"Aberhart Centre One, Room 9418; Evidence-based Practice Centre; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry P","family":"Klassen","sequence":"additional","affiliation":[{"name":"Manitoba Institute of Child Health; Winnipeg Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hartling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and the Alberta Research Centre for Health Evidence; University of Alberta; Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD005220.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1212\/01.WNL.0000115105.05966.A7","article-title":"Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial","volume":"62","author":"Ahonen","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD005220.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1212\/01.wnl.0000238179.79888.44","article-title":"A randomized trial of rizatriptan in migraine attacks in children","volume":"67","author":"Ahonen","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD005220.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejpn.2007.02.010","article-title":"Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children","volume":"11","author":"Callenbach","year":"2007","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0004|cit4","unstructured":"A multi-centre, randomised, double-blind, placebo-controlled, cross-over study to investigate the efficacy, safety and tolerability of sumatriptan nasal spray (10mg or 20mg) in the treatment of migraine in patients aged 12-17 http:\/\/www.gsk-clinicalstudyregister.com\/study\/SUM30042#rs"},{"issue":"6","key":"10.1002\/14651858.CD005220.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"e1411","DOI":"10.1542\/peds.2011-2455","article-title":"Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine","volume":"129","author":"Derosier","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD005220.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1212\/01.wnl.0000231138.18629.d5","article-title":"Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen","volume":"67","author":"Evers","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005220.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0333102413510213","article-title":"Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study","volume":"34","author":"Fujita","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0008|cit8","unstructured":"A randomized, multicenter, placebo-controlled, parallel group study to evaluate the efficacy and safety of oral sumatriptan for the acute treatment of migraine in children and adolescents http:\/\/www.gsk-clinicalstudyregister.com\/study\/111035#ps"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1212\/WNL.48.1.103","article-title":"Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD005220.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.48.4.1100","article-title":"Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0887-8994(96)00289-5","article-title":"Oral dihydroergotamine for therapy-resistant migraine attacks in children","volume":"16","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Pediatric Neurology"},{"issue":"9","key":"10.1002\/14651858.CD005220.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1742-1241.2002.tb11356.x","article-title":"Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger","volume":"56","author":"H\u00e4m\u00e4l\u00e4inen","year":"2002","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0013|cit13","unstructured":"A single centre, placebo-controlled, double blind, randomised cross-over, single attack study evaluating the efficacy and tolerability of sumatriptan nasal spray 10 mg for the acute treatment of migraine in children suffering from refractory migraine with\/without aura http:\/\/www.gsk-clinicalstudyregister.com\/study\/SUM30009#rs"},{"issue":"10","key":"10.1002\/14651858.CD005220.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/0333102412451358","article-title":"Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design","volume":"32","author":"Ho","year":"2012","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD005220.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children's ibuprofen suspension for the acute treatment of pediatric migraine","volume":"42","author":"Lewis","year":"2002","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1542\/peds.2007-0085","article-title":"Efficacy of zolmitriptan nasal spray in adolescent migraine","volume":"120","author":"Lewis","year":"2007","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD005220.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1526-4610.2008.01138.x","article-title":"Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial","volume":"48","author":"Linder","year":"2008","journal-title":"Headache"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0018|cit18","unstructured":"Zomig - treatment of acute migraine headache in adolescents (TEENZ) clinicaltrials.gov\/ct2\/show\/NCT01211145"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005220.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0022-510X(97)85361-0","article-title":"Efficacy and safety of naratriptan tablets in adolescent migraine","volume":"150","author":"Rothner","year":"1997","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0020|cit20","unstructured":"A randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy, safety and tolerability of oral naratriptan in an adolescent migraine population http:\/\/www.gsk-clinicalstudyregister.com\/study\/S2WA3012#rs"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005220.pub2-BIB0021|cit21","first-page":"106","article-title":"Tolerability of sumatriptan tablets in the acute treatment of migraine in adolescent patients: a review of data from clinical trials","volume":"6","author":"Rothner","year":"1999","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0022|cit22","unstructured":"A double-blind, randomised, placebo-controlled study to compare the efficacy and safety of oral sumatriptan (25mg, 50mg and 100mg) in the acute treatment of migraine in adolescents http:\/\/www.gsk-clinicalstudyregister.com\/study\/SUMB2003#rs"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005220.pub2-BIB0023|cit23","first-page":"106","article-title":"Tolerability of sumatriptan tablets in the acute treatment of migraine in adolescent patients: a review of data from clinical trials","volume":"6","author":"Rothner","year":"1999","journal-title":"European Journal of Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005220.pub2-BIB0024|cit24","first-page":"106","article-title":"Tolerability of sumatriptan tablets in the acute treatment of migraine in adolescent patients: a review of data from clinical trials","volume":"6","author":"Rother","year":"1999","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1526-4610.2006.00313.x","article-title":"Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents","volume":"46","author":"Rothner","year":"2006","journal-title":"Headache"},{"issue":"7","key":"10.1002\/14651858.CD005220.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.52.7.1507","article-title":"Intranasal sumatriptan for the acute treatment of migraine in children","volume":"52","author":"Ueberall","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1526-4610.2004.04171.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies","volume":"44","author":"Visser","year":"2004","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005220.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/S0022-510X(97)85694-8","article-title":"Adolescent migraine: efficacy and safety of sumatriptan tablets","volume":"150","author":"Winner","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD005220.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1542\/peds.106.5.989","article-title":"A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents","volume":"106","author":"Winner","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1526-4610.2002.02013.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study","volume":"42","author":"Winner","year":"2002","journal-title":"Headache"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0031|cit31","unstructured":"A double-blind, placebo-controlled, parallel group study to evaluate two dose levels (5mg And 20mg) of sumatriptan nasal spray in the acute treatment of a single migraine attack in adolescent migraineurs (12-17 years of age) http:\/\/www.gsk-clinicalstudyregister.com\/study\/SUM30045#rs"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1526-4610.2006.00339.x","article-title":"Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study","volume":"46","author":"Winner","year":"2006","journal-title":"Headache"},{"issue":"7 Suppl 5","key":"10.1002\/14651858.CD005220.pub2-BIB0033|cit33","first-page":"A182","article-title":"Randomized, double-blind, placebo- controlled study of sumatriptan nasal spray in adolescent migraineurs","volume":"62","author":"Winner","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005220.pub2-BIB0034|cit34","first-page":"424","article-title":"Efficacy, safety and tolerability of oral eletriptan (40 mg) for the treatment of migraine in adolescents (12-17 years)","volume":"40","author":"Pitman","year":"2000","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD005220.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1526-4610.2007.00755.x","article-title":"Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial","volume":"47","author":"Winner","year":"2007","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","article-title":"Treatment of pediatric migraines: a randomized, double-blind trial of prochlorperazine versus ketorolac","volume":"43","author":"Brousseau","year":"2004","journal-title":"Annals of Emergency Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005220.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1526-4610.2011.01910.x","article-title":"A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesicTM M) in the treatment of migraine","volume":"51","author":"Cady","year":"2011","journal-title":"Headache"},{"issue":"S15","key":"10.1002\/14651858.CD005220.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1002\/ana.22563","article-title":"Intravenous magnesium as abortive treatment for headaches in children","volume":"70","author":"Gertsch","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0039|cit39","unstructured":"Treatment of acute migraine headache in children clinicaltrials.gov\/show\/NCT00355394"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0040|cit40","first-page":"233","article-title":"Nimesulide and acetaminophen for the treatment of juvenile migraine: a study for comparison of efficacy, safety, and tolerability","volume":"12","author":"Soriani","year":"2001","journal-title":"Headache Quarterly"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0041|cit41","unstructured":"The use of oral sumatriptan on compassionate grounds for the acute treatment of migraine in adolescent patients (ages 12 to 17) http:\/\/www.gsk-clinicalstudyregister.com\/study\/SUM40090#rs"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.brat.2009.09.004","article-title":"A randomized controlled trial of Internet-based self-help training for recurrent headache in childhood and adolescence","volume":"48","author":"Trautmann","year":"2010","journal-title":"Behaviour Research & Therapy"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/JPN-2011-0471","article-title":"Sumatriptan formulated with RT technologyTM as early intervention for migraine in adolescents","volume":"9","author":"Winner","year":"2011","journal-title":"Journal of Pediatric Neurology"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0044|cit44","unstructured":"Treximet Early Intervention Adolescent Migraine (TEAM) clinicaltrials.gov\/ct2\/show\/NCT01016678"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/head.12555","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescents","volume":"55","author":"Winner","year":"2015","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD005220.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1046\/j.1468-2982.1997.1704488.x","article-title":"A 40-year follow-up of school children with migraine","volume":"17","author":"Bille","year":"1997","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0032-1330856","article-title":"Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache","volume":"44","author":"Bonfert","year":"2013","journal-title":"Neuropediatrics"},{"issue":"15","key":"10.1002\/14651858.CD005220.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1002\/sim.1206","article-title":"Meta-analysis combining parallel and cross-over clinical trials. II: binary outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1542\/peds.2004-2742","article-title":"Symptomatic treatment of migraine in children: a systematic review of medication trials","volume":"116","author":"Damen","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD005220.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1046\/j.1468-2982.2000.00082.x","article-title":"Determinants of patient satisfaction with migraine therapy","volume":"20","author":"Davies","year":"2000","journal-title":"Cephalalgia"},{"issue":"7109","key":"10.1002\/14651858.CD005220.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD005220.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/11532860-000000000-00000","article-title":"The use of triptans for pediatric migraines","volume":"12","author":"Eiland","year":"2010","journal-title":"Paediatric Drugs"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005220.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1468-2982.2008.01689.x","article-title":"The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0054|cit54","unstructured":"GRADEpro Guideline Development Tool McMaster University (developed by Evidence Prime, Inc.) 2015"},{"issue":"20","key":"10.1002\/14651858.CD005220.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005220.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0057|cit57","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from: www.cochrane-handbook.org"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD005220.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2982.2003.00823.x","article-title":"The International Classification of Headache Disorders, 2nd edition","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD005220.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD005220.pub2-BIB0060|cit60","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain","volume":"8","author":"International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/ije\/dym001","article-title":"Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials","volume":"36","author":"Lathyris","year":"2007","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD005220.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1460-9568.2008.06068.x","article-title":"Sensitization of meningeal nociceptors: inhibition by naproxen","volume":"27","author":"Levy","year":"2008","journal-title":"European Journal of Neuroscience"},{"issue":"12","key":"10.1002\/14651858.CD005220.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","article-title":"Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society","volume":"63","author":"Lewis","year":"2004","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005220.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","article-title":"What do patients with migraine want from acute migraine treatment?","volume":"42","author":"Lipton","year":"2002","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD005220.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0887-8994(03)00400-4","article-title":"Triptans for treatment of acute pediatric migraine: a systematic literature review","volume":"29","author":"Major","year":"2003","journal-title":"Pediatric Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005220.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1345\/aph.1M332","article-title":"Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review","volume":"44","author":"Pierce","year":"2010","journal-title":"Annals of Pharmacotherapy"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD005220.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.112.1.e1","article-title":"Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses","volume":"112","author":"Powers","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD005220.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1468-2982.2004.00652.x","article-title":"Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0","volume":"24","author":"Powers","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0069|cit69","unstructured":"Review Manager Cochrane 2014"},{"issue":"1-2","key":"10.1002\/14651858.CD005220.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1440-1754.2007.01206.x","article-title":"Acute treatment of paediatric migraine: a meta-analysis of efficacy","volume":"44","author":"Silver","year":"2008","journal-title":"Journal of Paediatrics & Child Health"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0071|cit71","unstructured":"Stata Statistical Software: Release 14 StataCorp LP 2015"},{"issue":"3","key":"10.1002\/14651858.CD005220.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","article-title":"The global burden of headache: a documentation of headache prevalence and disability worldwide","volume":"27","author":"Stovner","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Sun H Bastings E Temeck J Men A Tandon V Murphy D Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents JAMA Pediatrics 2013 167 3 243 9 10.1001\/jamapediatrics.2013.872","DOI":"10.1001\/jamapediatrics.2013.872"},{"issue":"5","key":"10.1002\/14651858.CD005220.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1526-4610.2010.01635.x","article-title":"Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine","volume":"50","author":"Suthisisang","year":"2010","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD005220.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0333102411417901","article-title":"Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators","volume":"32","author":"Tfelt-Hansen","year":"2012","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD005220.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1586\/ern.12.104","article-title":"The pharmacological treatment of migraine in children and adolescents: an overview","volume":"12","author":"Toldo","year":"2012","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD005220.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1586\/ern.10.147","article-title":"Triptans other than sumatriptan in child and adolescent migraine: literature review","volume":"11","author":"Vollono","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"7","key":"10.1002\/14651858.CD005220.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1526-4610.1995.hed3507407.x","article-title":"Classification of pediatric migraine: proposed revisions to the IHS criteria","volume":"35","author":"Winner","year":"1995","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD005220.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40272-013-0019-3","article-title":"Pharmacological treatment of acute migraine in adolescents and children","volume":"15","year":"2013","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD005220.pub2-BIB0080|cit80","volume-title":"Practice Variation in the Treatment of Children with Migraine in the Emergency Department [MSc Thesis]","author":"Richer","year":"2009"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005220.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T03:03:05Z","timestamp":1728961385000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005220.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":80,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005220.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}